Evidence map›Paper›PMID 40420687›Full record

ArticleAnimal models and experimental medicine2025

A mouse model of lung ischemia-reperfusion injury with reversible left hilar entrapment.

GuangDong Weng, Yao Chen, ShanQing Bao, ChengXin Zhang, WenHui Gong

Abstract read
In one paragraph

Article in Animal models and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

GuangDong WengDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0009-0000-8869-4796
Yao ChenDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ShanQing BaoDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ChengXin ZhangDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
WenHui GongDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

Natural Science Foundation of Anhui Province 1908085MH241
6 · The paper itself

Abstract

Lung ischemia-reperfusion injury (LIRI), an acute lung injury syndrome triggered by lung transplantation or distal organ ischemia, has long been a difficult and hot issue in clinical research. In this study, we proposed a simple and less invasive reversible LIRI surgical protocol, achieved by improving the mouse left hilar entrapment model, which significantly improved the operability of the experiment and the reproducibility of the results. The protocol achieves precise control of the ischemic and reperfusion processes by visualizing transoral intubation, using reversible ligation of live knots to clamp the left hilar, and temporary closure of the thoracic cavity during ischemia. The reversible survival model we constructed not only provides a reliable tool to study the cellular and molecular mechanisms of LIRI but also can be used to assess the stage of injury regression, experimental pneumonia, and survival in mice. In addition, it simplifies the lung portal separation clamping operation for reversible clamping and provides an easy-to-learn visual tracheal intubation method that can be quickly mastered and replicated by beginners for consistent and reliable results.

Indexed as

Acute Lung InjuryDisease Models, AnimalLungReperfusion InjuryAnimalsMaleMiceMice, Inbred C57BLlung ischemia–reperfusion injuryreversible clampingvisual tracheal intubation

Identifiers

PMID40420687
PMCPMC12531116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.